510(k) K910541
K910541 is an FDA 510(k) premarket notification submitted by Biokit USA, Inc. for the device "BIOKIT RPR". The FDA issued a decision of Substantially Equivalent on October 18, 1991. The device falls under product code GMQ (Antigens, Nontreponemal, All), a Class II device regulated under 21 CFR 866.3820. Biokit USA, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 18, 1991
- Date Received
- February 4, 1991
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antigens, Nontreponemal, All
- Device Class
- Class II
- Regulation Number
- 866.3820
- Review Panel
- MI
- Submission Type